These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(Mark One)
|
|
|
ý
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.
|
|
For the quarterly period ended: March 31, 2017
|
|
|
Or
|
|
|
o
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
For the transition period from to
|
|
|
Commission file number 1-37654
|
|
|
Delaware
|
|
47-5654583
|
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. employer
identification number)
|
|
|
|
|
|
6920 Seaway Blvd
Everett, WA
|
|
98203
|
|
(Address of principal executive offices)
|
|
(Zip code)
|
|
Large accelerated filer
¨
|
|
|
|
Accelerated filer
¨
|
|
|
|
|
|
|
|
Non-accelerated filer
x
|
|
(Do not check if a smaller reporting company)
|
|
Smaller reporting company
¨
|
|
|
|
|
|
|
|
|
|
|
|
Emerging growth company
¨
|
|
|
|
PART I -
|
FINANCIAL INFORMATION
|
Page
|
|
Item 1.
|
|
|
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
|
||
|
Item 2.
|
||
|
Item 3.
|
||
|
Item 4.
|
||
|
PART II -
|
OTHER INFORMATION
|
|
|
Item 1A.
|
||
|
Item 6.
|
||
|
|
||
|
|
As of
|
||||||
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
|
|
(unaudited)
|
|
|
||||
|
ASSETS
|
|
|
|
||||
|
Current assets:
|
|
|
|
||||
|
Cash and equivalents
|
$
|
817.6
|
|
|
$
|
803.2
|
|
|
Accounts receivable, net
|
944.1
|
|
|
945.4
|
|
||
|
Inventories:
|
|
|
|
||||
|
Finished goods
|
209.9
|
|
|
198.3
|
|
||
|
Work in process
|
90.1
|
|
|
79.3
|
|
||
|
Raw materials
|
271.6
|
|
|
267.0
|
|
||
|
Total inventories
|
571.6
|
|
|
544.6
|
|
||
|
Prepaid expenses and other current assets
|
184.1
|
|
|
195.5
|
|
||
|
Total current assets
|
2,517.4
|
|
|
2,488.7
|
|
||
|
Property, plant and equipment, net of accumulated depreciation of $1,027.6 and $1,004.2 at March 31, 2017 and December 31, 2016, respectively
|
552.9
|
|
|
547.6
|
|
||
|
Other assets
|
428.6
|
|
|
427.2
|
|
||
|
Goodwill
|
3,999.2
|
|
|
3,979.0
|
|
||
|
Other intangible assets, net
|
736.2
|
|
|
747.3
|
|
||
|
Total assets
|
$
|
8,234.3
|
|
|
$
|
8,189.8
|
|
|
LIABILITIES AND EQUITY
|
|
|
|
||||
|
Current liabilities:
|
|
|
|
||||
|
Trade accounts payable
|
$
|
623.3
|
|
|
$
|
666.2
|
|
|
Accrued expenses and other current liabilities
|
777.7
|
|
|
800.3
|
|
||
|
Total current liabilities
|
1,401.0
|
|
|
1,466.5
|
|
||
|
Other long-term liabilities
|
678.7
|
|
|
674.3
|
|
||
|
Long-term debt
|
3,262.7
|
|
|
3,358.0
|
|
||
|
Equity:
|
|
|
|
||||
|
Preferred stock: $0.01 par value, 15 million shares authorized; no shares issued or outstanding
|
—
|
|
|
—
|
|
||
|
Common stock: $0.01 par value, 2.0 billion shares authorized; 346.8 million and 346.0 million issued; 346.6 million and 345.9 million outstanding at March 31, 2017 and December 31,2016, respectively
|
3.5
|
|
|
3.5
|
|
||
|
Additional paid-in capital
|
2,407.8
|
|
|
2,427.2
|
|
||
|
Retained earnings
|
578.5
|
|
|
403.0
|
|
||
|
Accumulated other comprehensive income (loss)
|
(101.4
|
)
|
|
(145.8
|
)
|
||
|
Total Fortive stockholders’ equity
|
2,888.4
|
|
|
2,687.9
|
|
||
|
Noncontrolling interests
|
3.5
|
|
|
3.1
|
|
||
|
Total stockholders’ equity
|
2,891.9
|
|
|
2,691.0
|
|
||
|
Total liabilities and equity
|
$
|
8,234.3
|
|
|
$
|
8,189.8
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2017
|
|
April 1, 2016
|
||||
|
Sales
|
$
|
1,535.2
|
|
|
$
|
1,474.7
|
|
|
Cost of sales
|
(791.2
|
)
|
|
(779.5
|
)
|
||
|
Gross profit
|
744.0
|
|
|
695.2
|
|
||
|
Operating costs:
|
|
|
|
||||
|
Selling, general and administrative expenses
|
(352.9
|
)
|
|
(338.5
|
)
|
||
|
Research and development expenses
|
(96.2
|
)
|
|
(93.7
|
)
|
||
|
Operating profit
|
294.9
|
|
|
263.0
|
|
||
|
Non-operating expense:
|
|
|
|
||||
|
Interest expense
|
(22.6
|
)
|
|
—
|
|
||
|
Earnings before income taxes
|
272.3
|
|
|
263.0
|
|
||
|
Income taxes
|
(72.6
|
)
|
|
(81.0
|
)
|
||
|
Net earnings
|
$
|
199.7
|
|
|
$
|
182.0
|
|
|
Net earnings per share:
|
|
|
|
||||
|
Basic
|
$
|
0.58
|
|
|
$
|
0.53
|
|
|
Diluted
|
$
|
0.57
|
|
|
$
|
0.53
|
|
|
Average common stock and common equivalent shares outstanding:
|
|
|
|
||||
|
Basic
|
347.0
|
|
|
345.2
|
|
||
|
Diluted
|
351.5
|
|
|
345.2
|
|
||
|
|
Three Months Ended
|
||||||
|
|
March 31, 2017
|
|
April 1, 2016
|
||||
|
Net earnings
|
$
|
199.7
|
|
|
$
|
182.0
|
|
|
Other comprehensive income (loss), net of income taxes:
|
|
|
|
||||
|
Foreign currency translation adjustments
|
43.6
|
|
|
22.1
|
|
||
|
Pension adjustments
|
0.8
|
|
|
1.0
|
|
||
|
Total other comprehensive income (loss), net of income taxes
|
44.4
|
|
|
23.1
|
|
||
|
Comprehensive income
|
$
|
244.1
|
|
|
$
|
205.1
|
|
|
|
Common Stock
|
|
Additional Paid-In Capital
|
|
Retained Earnings
|
|
Accumulated
Other
Comprehensive
Income (Loss)
|
|
Noncontrolling
Interests
|
|||||||||||||
|
|
Shares
|
|
Amount
|
|||||||||||||||||||
|
Balance, December 31, 2016
|
345.9
|
|
|
$
|
3.5
|
|
|
$
|
2,427.2
|
|
|
$
|
403.0
|
|
|
$
|
(145.8
|
)
|
|
$
|
3.1
|
|
|
Net earnings for the period
|
—
|
|
|
—
|
|
|
—
|
|
|
199.7
|
|
|
—
|
|
|
—
|
|
|||||
|
Dividends to shareholders
|
—
|
|
|
—
|
|
|
—
|
|
|
(24.2
|
)
|
|
—
|
|
|
—
|
|
|||||
|
Separation related adjustments
|
—
|
|
|
—
|
|
|
(33.6
|
)
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Other comprehensive income
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
44.4
|
|
|
—
|
|
|||||
|
Common stock-based award activity
|
0.7
|
|
|
—
|
|
|
14.2
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|||||
|
Change in noncontrolling interests
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
—
|
|
|
0.4
|
|
|||||
|
Balance, March 31, 2017
|
346.6
|
|
|
$
|
3.5
|
|
|
$
|
2,407.8
|
|
|
$
|
578.5
|
|
|
$
|
(101.4
|
)
|
|
$
|
3.5
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2017
|
|
April 1, 2016
|
||||
|
Cash flows from operating activities:
|
|
|
|
||||
|
Net earnings
|
$
|
199.7
|
|
|
$
|
182.0
|
|
|
Noncash items:
|
|
|
|
||||
|
Depreciation
|
23.4
|
|
|
21.5
|
|
||
|
Amortization
|
13.3
|
|
|
22.4
|
|
||
|
Stock-based compensation expense
|
12.0
|
|
|
11.5
|
|
||
|
Change in accounts receivable, net
|
10.0
|
|
|
61.0
|
|
||
|
Change in inventories
|
(24.2
|
)
|
|
(24.6
|
)
|
||
|
Change in trade accounts payable
|
(47.5
|
)
|
|
(39.0
|
)
|
||
|
Change in prepaid expenses and other assets
|
(0.6
|
)
|
|
5.4
|
|
||
|
Change in accrued expenses and other liabilities
|
(37.8
|
)
|
|
(63.0
|
)
|
||
|
Net cash provided by operating activities
|
148.3
|
|
|
177.2
|
|
||
|
Cash flows from investing activities:
|
|
|
|
||||
|
Cash paid for acquisitions
|
—
|
|
|
(12.8
|
)
|
||
|
Payments for additions to property, plant and equipment
|
(26.8
|
)
|
|
(28.4
|
)
|
||
|
All other investing activities
|
(0.6
|
)
|
|
2.0
|
|
||
|
Net cash used in investing activities
|
(27.4
|
)
|
|
(39.2
|
)
|
||
|
Cash flows from financing activities:
|
|
|
|
||||
|
Net repayments of borrowings (maturities of 90 days or less)
|
(95.5
|
)
|
|
—
|
|
||
|
Payment of dividends
|
(24.2
|
)
|
|
—
|
|
||
|
Net transfers to Former Parent
|
—
|
|
|
(138.0
|
)
|
||
|
All other financing activities
|
0.3
|
|
|
—
|
|
||
|
Net cash used in financing activities
|
(119.4
|
)
|
|
(138.0
|
)
|
||
|
Effect of exchange rate changes on cash and equivalents
|
12.9
|
|
|
—
|
|
||
|
Net change in cash and equivalents
|
14.4
|
|
|
—
|
|
||
|
Beginning balance of cash and equivalents
|
803.2
|
|
|
—
|
|
||
|
Ending balance of cash and equivalents
|
$
|
817.6
|
|
|
$
|
—
|
|
|
•
|
The Consolidated Condensed Balance Sheets at
March 31, 2017
and
December 31, 2016
consist of our consolidated balances.
|
|
•
|
The Consolidated Condensed Statement of Earnings, Statement of Comprehensive Income, Statement of Changes in Equity and Statement of Cash Flows for the three months ended
March 31, 2017
consist of our consolidated results. The Combined Condensed Statement of Earnings, Statement of Comprehensive Income and Statement of Cash Flows for the three months ended
April 1, 2016
, consist of the combined results of the Fortive Businesses.
|
|
|
Foreign
currency
translation
adjustments
|
|
Pension &
post-
retirement
plan benefit
adjustments
(b)
|
|
Total
|
||||||
|
For the Three Months Ended March 31, 2017:
|
|
|
|
|
|
||||||
|
Balance, December 31, 2016
|
$
|
(72.6
|
)
|
|
$
|
(73.2
|
)
|
|
$
|
(145.8
|
)
|
|
Other comprehensive income (loss) before reclassifications, net of income taxes
|
43.6
|
|
|
—
|
|
|
43.6
|
|
|||
|
Amounts reclassified from accumulated other comprehensive income (loss):
|
|
|
|
|
|
||||||
|
Increase (decrease)
|
—
|
|
|
1.1
|
|
(a)
|
1.1
|
|
|||
|
Income tax impact
|
—
|
|
|
(0.3
|
)
|
|
(0.3
|
)
|
|||
|
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes
|
—
|
|
|
0.8
|
|
|
0.8
|
|
|||
|
Net current period other comprehensive income (loss), net of income taxes
|
43.6
|
|
|
0.8
|
|
|
44.4
|
|
|||
|
Balance, March 31, 2017
|
$
|
(29.0
|
)
|
|
$
|
(72.4
|
)
|
|
$
|
(101.4
|
)
|
|
|
|
|
|
|
|
||||||
|
For the Three Months Ended April 1, 2016:
|
|
|
|
|
|
||||||
|
Balance, December 31, 2015
|
$
|
51.2
|
|
|
$
|
(65.6
|
)
|
|
$
|
(14.4
|
)
|
|
Other comprehensive income (loss) before reclassifications, net of income taxes
|
22.1
|
|
|
—
|
|
|
22.1
|
|
|||
|
Amounts reclassified from accumulated other comprehensive income (loss):
|
|
|
|
|
|
||||||
|
Increase (decrease)
|
—
|
|
|
1.3
|
|
(a)
|
1.3
|
|
|||
|
Income tax impact
|
—
|
|
|
(0.3
|
)
|
|
(0.3
|
)
|
|||
|
Amounts reclassified from accumulated other comprehensive income (loss), net of income taxes
|
—
|
|
|
1.0
|
|
|
1.0
|
|
|||
|
Net current period other comprehensive income (loss), net of income taxes
|
22.1
|
|
|
1.0
|
|
|
23.1
|
|
|||
|
Balance, April 1, 2016
|
$
|
73.3
|
|
|
$
|
(64.6
|
)
|
|
$
|
8.7
|
|
|
|
|
|
|
|
|
||||||
|
(a)
This accumulated other comprehensive income (loss) component is included in the computation of net periodic pension cost (refer to Note 6 for additional details).
|
|||||||||||
|
(b)
Includes balances relating to non-U.S. employee defined benefit plans, supplemental executive retirement plans and other postretirement employee benefit plans.
|
|||||||||||
|
|
|
|
|
|
|
|
Balance, December 31, 2016
|
$
|
3,979.0
|
|
|
Foreign currency translation & other
|
20.2
|
|
|
|
Balance, March 31, 2017
|
$
|
3,999.2
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
|
Professional Instrumentation
|
$
|
2,435.9
|
|
|
$
|
2,423.7
|
|
|
Industrial Technologies
|
1,563.3
|
|
|
1,555.3
|
|
||
|
Total goodwill
|
$
|
3,999.2
|
|
|
$
|
3,979.0
|
|
|
|
Quoted Prices
in Active
Market
(Level 1)
|
|
Significant Other
Observable Inputs
(Level 2)
|
|
Significant
Unobservable
Inputs
(Level 3)
|
|
Total
|
||||||||
|
March 31, 2017
|
|
|
|
|
|
|
|
||||||||
|
Deferred compensation liabilities
|
$
|
—
|
|
|
$
|
17.9
|
|
|
$
|
—
|
|
|
$
|
17.9
|
|
|
December 31, 2016
|
|
|
|
||||||||||||
|
Deferred compensation liabilities
|
$
|
—
|
|
|
$
|
14.8
|
|
|
$
|
—
|
|
|
$
|
14.8
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||||||||||
|
|
Carrying Amount
|
|
Fair Value
|
|
Carrying Amount
|
|
Fair Value
|
||||||||
|
Long-term borrowings
|
$
|
3,262.7
|
|
|
$
|
3,240.5
|
|
|
$
|
3,358.0
|
|
|
$
|
3,321.4
|
|
|
|
March 31, 2017
|
|
December 31, 2016
|
||||
|
U.S. dollar-denominated commercial paper
|
$
|
118.5
|
|
|
$
|
347.9
|
|
|
Euro-denominated commercial paper
|
160.3
|
|
|
26.8
|
|
||
|
Variable interest rate term loan
|
500.0
|
|
|
500.0
|
|
||
|
1.80% senior unsecured notes due 2019
|
298.4
|
|
|
298.3
|
|
||
|
2.35% senior unsecured notes due 2021
|
745.1
|
|
|
744.8
|
|
||
|
3.15% senior unsecured notes due 2026
|
890.4
|
|
|
890.1
|
|
||
|
4.30% senior unsecured notes due 2046
|
546.8
|
|
|
546.8
|
|
||
|
Other
|
3.2
|
|
|
3.3
|
|
||
|
Long-term debt
|
$
|
3,262.7
|
|
|
$
|
3,358.0
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2017
|
|
April 1, 2016
|
||||
|
Service cost
|
$
|
1.0
|
|
|
$
|
0.8
|
|
|
Interest cost
|
1.4
|
|
|
1.9
|
|
||
|
Expected return on plan assets
|
(1.8
|
)
|
|
(2.0
|
)
|
||
|
Amortization of net loss
|
1.1
|
|
|
1.3
|
|
||
|
Net periodic pension cost
|
$
|
1.7
|
|
|
$
|
2.0
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2017
|
|
April 1, 2016
|
||||
|
Stock Awards:
|
|
|
|
||||
|
Pretax compensation expense
|
$
|
7.4
|
|
|
$
|
7.1
|
|
|
Income tax benefit
|
(2.5
|
)
|
|
(2.3
|
)
|
||
|
Stock Award expense, net of income taxes
|
4.9
|
|
|
4.8
|
|
||
|
Stock options:
|
|
|
|
||||
|
Pretax compensation expense
|
4.6
|
|
|
4.4
|
|
||
|
Income tax benefit
|
(1.6
|
)
|
|
(1.5
|
)
|
||
|
Stock option expense, net of income taxes
|
3.0
|
|
|
2.9
|
|
||
|
Total stock-based compensation:
|
|
|
|
||||
|
Pretax compensation expense
|
12.0
|
|
|
11.5
|
|
||
|
Income tax benefit
|
(4.1
|
)
|
|
(3.8
|
)
|
||
|
Total stock-based compensation expense, net of income taxes
|
$
|
7.9
|
|
|
$
|
7.7
|
|
|
Stock Awards
|
$
|
60.1
|
|
|
Stock options
|
54.9
|
|
|
|
Total unrecognized compensation cost
|
$
|
115.0
|
|
|
Risk-free interest rate
|
1.95% - 2.26%
|
|
|
Weighted average volatility
(a)
|
21.0
|
%
|
|
Dividend yield
|
0.5
|
%
|
|
Expected years until exercise
|
5.5 - 8.0
|
|
|
|
|
|
|
(a)
Weighted average volatility was estimated based on an average historical stock price volatility of a group of peer companies, given our limited trading history.
|
||
|
|
Options
|
|
Weighted
Average
Exercise
Price
|
|
Weighted Average
Remaining
Contractual Term
(in years)
|
|
Aggregate
Intrinsic
Value
|
|||||
|
Outstanding as of December 31, 2016
|
10.7
|
|
|
$
|
33.23
|
|
|
|
|
|
||
|
Granted
|
1.8
|
|
|
57.26
|
|
|
|
|
|
|||
|
Exercised
|
(0.3
|
)
|
|
25.35
|
|
|
|
|
|
|||
|
Canceled/forfeited
|
(0.1
|
)
|
|
39.83
|
|
|
|
|
|
|||
|
Outstanding as of March 31, 2017
|
12.1
|
|
|
$
|
36.86
|
|
|
6.8
|
|
$
|
282.3
|
|
|
Vested and expected to vest as of March 31, 2017
(a)
|
11.6
|
|
|
$
|
36.40
|
|
|
6.7
|
|
$
|
276.0
|
|
|
Vested as of March 31, 2017
|
5.3
|
|
|
$
|
26.49
|
|
|
4.7
|
|
$
|
180.4
|
|
|
|
|
|
|
|
|
|
|
|||||
|
(a)
The “expected to vest” options are the net unvested options that remain after applying the forfeiture rate assumption to total unvested options.
|
||||||||||||
|
|
Number of
Stock Awards
|
|
Weighted Average
Grant-Date
Fair Value
|
|||
|
Unvested as of December 31, 2016
|
2.2
|
|
|
$
|
39.20
|
|
|
Granted
|
0.6
|
|
|
56.69
|
|
|
|
Vested
|
(0.4
|
)
|
|
35.88
|
|
|
|
Unvested as of March 31, 2017
|
2.4
|
|
|
$
|
43.83
|
|
|
Balance, December 31, 2016
|
$
|
65.0
|
|
|
Accruals for warranties issued during the period
|
17.6
|
|
|
|
Settlements made
|
(17.4
|
)
|
|
|
Balance, March 31, 2017
|
$
|
65.2
|
|
|
|
Net Earnings (Numerator)
|
|
Shares (Denominator)
|
|
Per Share Amount
|
||||
|
For the Three Months Ended March 31, 2017:
|
|
|
|
|
|
||||
|
Basic EPS
|
$
|
199.7
|
|
|
347.0
|
|
$
|
0.58
|
|
|
Incremental shares from assumed exercise of dilutive options and vesting of dilutive Stock Awards
|
—
|
|
|
4.5
|
|
|
|||
|
Diluted EPS
|
$
|
199.7
|
|
|
351.5
|
|
$
|
0.57
|
|
|
|
|
|
|
|
|
||||
|
For the Three Months Ended April 1, 2016:
|
|
|
|
|
|
||||
|
Basic and diluted EPS
|
$
|
182.0
|
|
|
345.2
|
|
$
|
0.53
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
||||||
|
|
March 31, 2017
|
|
April 1, 2016
|
||||
|
Sales:
|
|
|
|
||||
|
Professional Instrumentation
|
$
|
716.1
|
|
|
$
|
697.4
|
|
|
Industrial Technologies
|
819.1
|
|
|
777.3
|
|
||
|
Total
|
$
|
1,535.2
|
|
|
$
|
1,474.7
|
|
|
Operating Profit:
|
|
|
|
||||
|
Professional Instrumentation
|
$
|
158.0
|
|
|
$
|
146.0
|
|
|
Industrial Technologies
|
152.6
|
|
|
130.7
|
|
||
|
Other
|
(15.7
|
)
|
|
(13.7
|
)
|
||
|
Total
|
$
|
294.9
|
|
|
$
|
263.0
|
|
|
•
|
Information Relating to Forward-Looking Statements
|
|
•
|
Basis of Presentation
|
|
•
|
Overview
|
|
•
|
Results of Operations
|
|
•
|
Liquidity and Capital Resources
|
|
•
|
Critical Accounting Estimates
|
|
•
|
Conditions in the global economy, the markets we serve and the financial markets may adversely affect our business and financial statements.
|
|
•
|
Our growth could suffer if the markets into which we sell our products, software and services decline, do not grow as anticipated or experience cyclicality.
|
|
•
|
We face intense competition and if we are unable to compete effectively, we may experience decreased demand and decreased market share. Even if we compete effectively, we may be required to reduce prices for our products, software and services.
|
|
•
|
Changes in industry standards, governmental regulations and applicable laws may reduce demand for our products or services or increase our expenses.
|
|
•
|
Any inability to consummate acquisitions at our historical rate and at appropriate prices could negatively impact our growth rate and stock price.
|
|
•
|
Our growth depends in part on the timely development and commercialization, and customer acceptance, of new and enhanced products, software and services based on technological innovation.
|
|
•
|
Our reputation, ability to do business and financial statements may be impaired by improper conduct by any of our employees, agents or business partners.
|
|
•
|
Our acquisition of businesses, joint ventures and strategic relationships could negatively impact our financial statements.
|
|
•
|
The indemnification provisions of acquisition agreements by which we have acquired companies may not fully protect us and as a result we may face unexpected liabilities.
|
|
•
|
Divestitures or other dispositions could negatively impact our business, and contingent liabilities from businesses that we have sold could adversely affect our financial statements.
|
|
•
|
Our operations, products and services expose us to the risk of environmental, health and safety liabilities, costs and violations that could adversely affect our reputation, business and financial statements.
|
|
•
|
Our businesses are subject to extensive regulation; failure to comply with those regulations could adversely affect our business, financial statements and reputation.
|
|
•
|
International economic, trade, political, legal, compliance and business factors could negatively affect our financial statements.
|
|
•
|
We may be required to recognize impairment charges for our goodwill and other intangible assets.
|
|
•
|
Foreign currency exchange rates may adversely affect our financial statements.
|
|
•
|
Changes in our tax rates or exposure to additional income tax liabilities or assessments could affect our profitability. In addition, audits by tax authorities could result in additional tax payments for prior periods.
|
|
•
|
We have incurred a significant amount of debt, and our debt will increase further if we incur additional debt and do not retire existing debt.
|
|
•
|
We are subject to a variety of litigation and other legal and regulatory proceedings in the course of our business that could adversely affect our financial statements.
|
|
•
|
If we do not or cannot adequately protect our intellectual property, or if third parties infringe our intellectual property rights, we may suffer competitive injury or expend significant resources enforcing our rights.
|
|
•
|
Third parties may claim that we are infringing or misappropriating their intellectual property rights and we could suffer significant litigation expenses, losses or licensing expenses or be prevented from selling products or services.
|
|
•
|
Defects and unanticipated use or inadequate disclosure with respect to our products, software or services could adversely affect our business, reputation and financial statements.
|
|
•
|
Adverse changes in our relationships with, or the financial condition, performance, purchasing patterns or inventory levels of, key distributors and other channel partners could adversely affect our financial statements.
|
|
•
|
Our financial results are subject to fluctuations in the cost and availability of commodities that we use in our operations.
|
|
•
|
If we cannot adjust our manufacturing capacity or the purchases required for our manufacturing activities to reflect changes in market conditions and customer demand, our profitability may suffer. In addition, our reliance upon sole
|
|
•
|
A significant disruption in, or breach in security of, our information technology systems could adversely affect our business.
|
|
•
|
Our restructuring actions could have long-term adverse effects on our business.
|
|
•
|
Work stoppages, union and works council campaigns and other labor disputes could adversely impact our productivity and results of operations.
|
|
•
|
If we suffer loss to our facilities, supply chains, distribution systems or information technology systems due to catastrophe or other events, our operations could be seriously harmed.
|
|
•
|
Certain provisions in our amended and restated certificate of incorporation and bylaws, and of Delaware law, may prevent or delay an acquisition of our company, which could decrease the trading price of our common stock.
|
|
•
|
Our amended and restated certificate of incorporation designates the state courts in the State of Delaware or, if no state court located within the State of Delaware has jurisdiction, the federal court for the District of Delaware, as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by our shareholders which could discourage lawsuits against us and our directors and officers.
|
|
•
|
As an independent, publicly traded company, we may not enjoy the same benefits that we did as a part of Danaher Corporation (“Danaher” or “Former Parent”).
|
|
•
|
Potential indemnification liabilities to Danaher pursuant to our separation agreement with Danaher could materially and adversely affect our businesses, financial condition, results of operations and cash flows.
|
|
•
|
In connection with our separation from Danaher, Danaher has indemnified us for certain liabilities. However, there can be no assurance that the indemnity will be sufficient to insure us against the full amount of such liabilities, or that Danaher’s ability to satisfy its indemnification obligation will not be impaired in the future.
|
|
•
|
There could be significant liability if the separation from Danaher fails to qualify as a tax-free transaction for U.S. federal income tax purposes.
|
|
•
|
We may not be able to engage in certain corporate transactions for a two-year period after the separation from Danaher on July 2, 2016.
|
|
|
% Change
Three Months Ended March 31, 2017 vs. Comparable 2016 Period |
|
|
Total revenue growth (GAAP)
|
4.1
|
%
|
|
Existing businesses (Non-GAAP)
|
4.9
|
%
|
|
Acquisitions
(a)
(Non-GAAP)
|
0.2
|
%
|
|
Currency exchange rates (Non-GAAP)
|
(1.0
|
)%
|
|
|
|
|
|
(a)
Includes the impact from both acquisitions and the Separation
|
||
|
|
Three Months Ended
|
||||||
|
|
March 31, 2017
|
|
April 1, 2016
|
||||
|
Professional Instrumentation
|
$
|
716.1
|
|
|
$
|
697.4
|
|
|
Industrial Technologies
|
819.1
|
|
|
777.3
|
|
||
|
Total
|
$
|
1,535.2
|
|
|
$
|
1,474.7
|
|
|
|
Three Months Ended
|
||||||
|
($ in millions)
|
March 31, 2017
|
|
April 1, 2016
|
||||
|
Sales
|
$
|
716.1
|
|
|
$
|
697.4
|
|
|
Operating profit
|
158.0
|
|
|
146.0
|
|
||
|
Depreciation
|
8.8
|
|
|
9.1
|
|
||
|
Amortization
|
7.8
|
|
|
17.0
|
|
||
|
Operating profit as a % of sales
|
22.1
|
%
|
|
20.9
|
%
|
||
|
Depreciation as a % of sales
|
1.2
|
%
|
|
1.3
|
%
|
||
|
Amortization as a % of sales
|
1.1
|
%
|
|
2.4
|
%
|
||
|
|
% Change
Three Months Ended March 31, 2017 vs. Comparable 2016 Period |
|
|
Total revenue growth (GAAP)
|
2.7
|
%
|
|
Existing businesses (Non-GAAP)
|
4.6
|
%
|
|
Acquisitions
(a)
(Non-GAAP)
|
(0.7
|
)%
|
|
Currency exchange rates (Non-GAAP)
|
(1.2
|
)%
|
|
|
|
|
|
(a)
Includes the impact from both acquisitions and the Separation
|
||
|
|
Three Months Ended
|
||||||
|
($ in millions)
|
March 31, 2017
|
|
April 1, 2016
|
||||
|
Sales
|
$
|
819.1
|
|
|
$
|
777.3
|
|
|
Operating profit
|
152.6
|
|
|
130.7
|
|
||
|
Depreciation
|
14.1
|
|
|
12.4
|
|
||
|
Amortization
|
5.5
|
|
|
5.4
|
|
||
|
Operating profit as a % of sales
|
18.6
|
%
|
|
16.8
|
%
|
||
|
Depreciation as a % of sales
|
1.7
|
%
|
|
1.6
|
%
|
||
|
Amortization as a % of sales
|
0.7
|
%
|
|
0.7
|
%
|
||
|
|
% Change
Three Months Ended March 31, 2017 vs. Comparable 2016 Period |
|
|
Total revenue growth (GAAP)
|
5.4
|
%
|
|
Existing businesses (Non-GAAP)
|
5.1
|
%
|
|
Acquisitions
(a)
(Non-GAAP)
|
1.1
|
%
|
|
Currency exchange rates (Non-GAAP)
|
(0.8
|
)%
|
|
|
|
|
|
(a)
Includes the impact from both acquisitions and the Separation
|
||
|
|
Three Months Ended
|
||||||
|
($ in millions)
|
March 31, 2017
|
|
April 1, 2016
|
||||
|
Sales
|
$
|
1,535.2
|
|
|
$
|
1,474.7
|
|
|
Cost of sales
|
(791.2
|
)
|
|
(779.5
|
)
|
||
|
Gross profit
|
$
|
744.0
|
|
|
$
|
695.2
|
|
|
Gross profit margin
|
48.5
|
%
|
|
47.1
|
%
|
||
|
|
Three Months Ended
|
||||||
|
($ in millions)
|
March 31, 2017
|
|
April 1, 2016
|
||||
|
Sales
|
$
|
1,535.2
|
|
|
$
|
1,474.7
|
|
|
Selling, general and administrative (“SG&A”) expenses
|
352.9
|
|
|
338.5
|
|
||
|
Research and development (“R&D”) expenses
|
96.2
|
|
|
93.7
|
|
||
|
SG&A as a % of sales
|
23.0
|
%
|
|
23.0
|
%
|
||
|
R&D as a % of sales
|
6.3
|
%
|
|
6.4
|
%
|
||
|
|
Three Months Ended
|
||||||
|
($ in millions)
|
March 31, 2017
|
|
April 1, 2016
|
||||
|
Net cash provided by operating activities
|
$
|
148.3
|
|
|
$
|
177.2
|
|
|
|
|
|
|
||||
|
Cash paid for acquisitions
|
$
|
—
|
|
|
$
|
(12.8
|
)
|
|
Payments for additions to property, plant and equipment
|
(26.8
|
)
|
|
(28.4
|
)
|
||
|
All other investing activities
|
(0.6
|
)
|
|
2.0
|
|
||
|
Net cash used in investing activities
|
$
|
(27.4
|
)
|
|
$
|
(39.2
|
)
|
|
|
|
|
|
||||
|
Net repayments of borrowings (maturities of 90 days or less)
|
$
|
(95.5
|
)
|
|
$
|
—
|
|
|
Payment of dividends
|
(24.2
|
)
|
|
—
|
|
||
|
Net transfers to Former Parent
|
—
|
|
|
(138.0
|
)
|
||
|
All other financing activities
|
0.3
|
|
|
—
|
|
||
|
Net cash used in financing activities
|
$
|
(119.4
|
)
|
|
$
|
(138.0
|
)
|
|
•
|
2017 operating cash flows benefited from higher net earnings for the first three months of 2017 as compared to the comparable period in 2016. Net earnings for the three months ended
March 31, 2017
reflected a decrease of
$7 million
of depreciation and amortization expense as compared to the comparable period of 2016 due primarily to certain intangible assets being fully amortized. Amortization expense primarily relates to the amortization of intangible assets acquired in connection with acquisitions. Depreciation expense relates primarily to our manufacturing and operating facilities. Depreciation and amortization are noncash expenses that decrease earnings without a corresponding impact to operating cash flows.
|
|
•
|
The aggregate of accounts receivable, inventories and trade accounts payable used
$62 million
of cash during the first three months of 2017 as compared to using
$3 million
of cash in the comparable period of 2016. The amount of cash flow generated from or used by the aggregate of accounts receivable, inventories and trade accounts payable depends upon how effectively we manage the cash conversion cycle, which effectively represents the number of days that elapse from the day we pay for the purchase of raw materials and components to the collection of cash from our customers and can be significantly impacted by the timing of collections and payments in a period.
|
|
•
|
The aggregate of prepaid expenses and other assets and accrued expenses and other liabilities used
$38 million
of cash during the first three months of 2017 as compared to using
$58 million
of cash in the comparable period of 2016. The timing of cash payments for income taxes and various employee related liabilities drove the majority of this change. During the three months ended April 1, 2016 our combined financial statements accounted for income taxes under the separate return method; accordingly our taxes payable during this period was an adjustment to equity as it did not represent a liability with the relevant taxing authorities as we were a part of Danaher’s tax returns during that time. We expect to make significant tax payments in the three months ending June 30, 2017.
|
|
|
|
|
|
Exhibit
Number
|
|
Description
|
|
3.1
|
|
|
|
|
|
|
|
3.2
|
|
|
|
|
|
|
|
10.1
|
|
|
|
|
|
|
|
11.1
|
|
|
|
|
|
|
|
31.1
|
|
|
|
|
|
|
|
31.2
|
|
|
|
|
|
|
|
32.1
|
|
|
|
|
|
|
|
32.2
|
|
|
|
|
|
|
|
101.INS
|
|
XBRL Instance Document* - the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.
|
|
|
|
|
|
101.SCH
|
|
XBRL Taxonomy Extension Schema Document*
|
|
|
|
|
|
101.CAL
|
|
XBRL Taxonomy Extension Calculation Linkbase Document*
|
|
|
|
|
|
101.DEF
|
|
XBRL Taxonomy Extension Definition Linkbase Document*
|
|
|
|
|
|
101.LAB
|
|
XBRL Taxonomy Extension Label Linkbase Document*
|
|
|
|
|
|
101.PRE
|
|
XBRL Taxonomy Extension Presentation Linkbase Document*
|
|
*
|
Attached as Exhibit 101 to this report are the following documents formatted in XBRL (Extensible Business Reporting Language): (i) Consolidated Condensed Balance Sheets as of
March 31, 2017
and December 31, 2016, (ii) Consolidated and Combined Condensed Statements of Earnings for the
three
months ended
March 31, 2017
and
April 1, 2016
, (iii)
|
|
|
FORTIVE CORPORATION:
|
|
|
|
|
|
|
Date: April 27, 2017
|
By:
|
/s/ Charles E. McLaughlin
|
|
|
|
Charles E. McLaughlin
|
|
|
|
Senior Vice President and Chief Financial Officer
|
|
|
|
|
|
Date: April 27, 2017
|
By:
|
/s/ Emily A. Weaver
|
|
|
|
Emily A. Weaver
|
|
|
|
Chief Accounting Officer
|
|
|
|
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|